HT
INO icon

Headlands Technologies’s Inovio Pharmaceuticals INO Stock Holding History

Headlands Technologies’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.9K Buy
+29,889
New +$35.5K ﹤0.01% 686
2025
Q4 		– Sell
-110,068
Closed -$258K – 756
2025
Q3 		$258K Buy
110,068
+109,730
+32,464% +$210K 0.02% 495
2025
Q2 		$688 Buy
+338
New +$648 ﹤0.01% 1135
2024
Q2 		– Sell
-1,360
Closed -$18.9K – 1357
2024
Q1 		$18.9K Buy
+1,360
New +$11.7K ﹤0.01% 921
2023
Q1 		– Sell
-275
Closed -$5K – 623
2022
Q4 		$5K Buy
+275
New +$6.23K ﹤0.01% 387

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Headlands Technologies's INO Position: Q2 2026 in Review

Headlands Technologies opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 29,889 shares worth $32.9K. The stake represents ﹤0.01% of the portfolio and ranks #686 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in INO as recently as Q3 2025.

Headlands Technologies first reported a position in INO in Q4 2022 and has held it in 5 quarters since. The position peaked at $258K in Q3 2025. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Headlands Technologies held 29,889 shares of Inovio Pharmaceuticals worth $32.9K as of Q2 2026.
  • Inovio Pharmaceuticals was a new Headlands Technologies position in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Headlands Technologies's portfolio in Q2 2026, its #686 holding.
  • Headlands Technologies first reported a position in Inovio Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
  • Headlands Technologies's Inovio Pharmaceuticals position peaked at $258K in Q3 2025.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.